Immunic, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 29.58 million compared to USD 25.27 million a year ago. Basic loss per share from continuing operations was USD 0.3 compared to USD 0.58 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.27 USD | +2.42% | +2.01% | -15.33% |
05-08 | Transcript : Immunic, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-08 | Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.33% | 112M | |
+11.83% | 116B | |
+12.13% | 106B | |
-9.14% | 23.89B | |
-2.88% | 21.58B | |
-11.00% | 18.96B | |
-40.50% | 16.96B | |
-14.23% | 16.33B | |
+6.67% | 14.14B | |
+30.68% | 12.02B |
- Stock Market
- Equities
- IMUX Stock
- News Immunic, Inc.
- Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024